January/February 2016

Pursuant to the Medicare Access & CHIP Reauthorization Act, CMS has released a draft Measure Development Plan detailing steps the federal government will take to incorporate measuring and reporting of quality measurements.

Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.

Looking forward to the Affordable Care Act in 2017, the patient community analyzes a list of improvements that HHS has proposed for the insurance marketplace.

Drug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.

Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.

The authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.

Without the use of comparative effectiveness as a strong part of the care decision-making process, we will never reach the goal of value-based care.